A 12-week double-blind randomised controlled trial investigating the effect of dietary supplementation with 125
Study Goal
The researchers aimed to investigate the effects of daily vitamin D supplementation on underlying inflammation and patient-focused outcomes in adults with asthma.
Results Summary
The abstract does not provide specific results regarding the effects of vitamin D supplementation.
Population
Adults with asthma
Effective Dosage
125 µg daily
Duration
12 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
- | increase | exacerbation | asthmatics | - | linked to higher rates | #1 |
- | decrease | lung function | asthmatics | - | linked to reduced | #2 |
vitamin D supplementation | neutral | - | children with asthma | - | investigating the effect | #3 |
vitamin D supplementation | neutral | bolus dosing regimens | adults | - | used | #4 |
vitamin D supplementation | no change | underlying inflammation | adults | - | main outcomes have been patient-focused without investigating | #5 |
daily 125 µg vitamin D | neutral | - | - | 125 µg | administering | #6 |
Vitamin D deficiency has previously been linked to higher rates of exacerbation and reduced lung function in asthmatics. Previous randomised controlled trials investigating the effect of vitamin D supplementation have mainly focused on children with asthma. Trials involving adults have typically used bolus dosing regimens, and the main outcomes have been patient-focused without investigating underlying inflammation. The present study aimed to conduct a 12-week placebo-controlled randomised controlled trials administering a daily 125 µg vitamin D